US Broker Ratings

PTC Therapeutics, Inc. (PTCT) Stock Analysis: Eyeing a 37% Upside in the Biotech Arena

PTC Therapeutics, Inc. (NASDAQ: PTCT) stands at the forefront of the biotechnology industry with its innovative focus on rare disorders. The company’s current market capitalization is $3.96 billion, reflecting its..

Belite Bio, Inc (BLTE) Stock Analysis: Biotechnology Innovator with 44.34% Upside Potential

Belite Bio, Inc (BLTE) is a promising player in the healthcare sector, specifically within the biotechnology industry. Based in San Diego, California, this clinical-stage biopharmaceutical company focuses on developing novel..

Harrow, Inc. (HROW) Stock Analysis: 56.84% Upside Potential in the Thriving Eyecare Pharmaceutical Market

For investors with an eye on the healthcare sector, Harrow, Inc. (NASDAQ: HROW) presents an intriguing opportunity. As a key player in the eyecare pharmaceutical industry, Harrow has carved out..

Innoviva, Inc. (INVA) Stock Analysis: Unraveling a 97% Potential Upside in Healthcare Innovation

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is capturing investors’ attention with its robust portfolio of pharmaceutical products and a significant potential upside of 97.31%. Headquartered..

Integra LifeSciences Holdings C (IART) Stock Analysis: Navigating a 12.99% Potential Upside Amidst Market Challenges

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a key player in the healthcare sector, specifically within the medical devices industry, finds itself at a pivotal juncture. With a market capitalization of..

Amedisys Inc (AMED) Stock Analysis: Navigating Growth in the Healthcare Sector

Amedisys Inc (NASDAQ: AMED), a prominent player in the healthcare sector, continues to capture investor attention with its robust service offerings and strategic positioning in the U.S. medical care facilities..

Aurinia Pharmaceuticals Inc (AUPH): Analyst Consensus and Growth Potential in Autoimmune Therapies

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) has carved out a niche within the biotechnology sector by focusing on therapies for autoimmune diseases, an area characterized by high unmet medical needs. With..

Surgery Partners, Inc. (SGRY): Investor Outlook on a Healthcare Innovator with 37.84% Upside Potential

Surgery Partners, Inc. (NASDAQ: SGRY) stands out as a dynamic entity within the healthcare sector, offering investors a unique proposition in the medical care facilities industry. Headquartered in Brentwood, Tennessee,..

HUTCHMED (China) Limited (HCM)

⚠️ No article content returned.

..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Navigating Challenges with a 13% Potential Upside

Brookdale Senior Living Inc. (NYSE: BKD) stands as a significant player within the healthcare sector, specifically in the medical care facilities industry. Headquartered in Brentwood, Tennessee, Brookdale operates a vast..

Adaptive Biotechnologies (ADPT) Stock Analysis: A Promising 12.81% Upside in the Evolving Biotech Sector

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands out in the biotechnology sector with its innovative approach to immune medicine through its proprietary immunosequencing platform. Headquartered in Seattle, Washington, this commercial-stage company..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Exploring a 16.5% Upside Potential in Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at the forefront of the healthcare sector, specializing in innovative non-opioid pain management solutions. With a market cap of $1.12 billion, this Tampa, Florida-based..

Organon & Co. (OGN) Stock Analysis: Exploring a 41.88% Potential Upside Amid Diverse Healthcare Offerings

Organon & Co. (NYSE: OGN) is carving its niche in the healthcare sector, particularly within the drug manufacturing industry. Headquartered in Jersey City, New Jersey, this company is a global..

10x Genomics, Inc. (TXG) Stock Analysis: Exploring a 12% Potential Upside Amidst Healthcare Innovation

10x Genomics, Inc. (NASDAQ: TXG) is a pivotal player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $1.68 billion, this Pleasanton, California-based..

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Evaluating Growth Potential Amidst CNS Drug Innovations

Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN), a key player in the healthcare sector, focuses on developing and commercializing treatments for central nervous system (CNS) disorders. With a current market capitalization of..

Novavax, Inc. (NVAX) Stock Analysis: Exploring a 35% Potential Upside Amid Biotech Challenges

Novavax, Inc. (NASDAQ: NVAX) finds itself at a pivotal juncture, presenting an intriguing opportunity for investors who are keen on the biotechnology sector. With a market capitalization of $1.58 billion..

Select Medical Holdings Corp (SEM) Stock Analysis: Exploring a 37.71% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) is drawing investor attention with its robust presence in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of..

PACS Group, Inc. (PACS) Stock Analysis: A 167% Potential Upside Beckons Investors

PACS Group, Inc. (PACS) is making waves in the healthcare sector, specifically in the medical care facilities industry. With a market capitalization of $1.77 billion, this Farmington, Utah-based company has..

MannKind Corporation (MNKD) Investor Outlook: Unpacking a 142.78% Potential Upside with Promising Biotech Innovations

MannKind Corporation (NASDAQ: MNKD), a trailblazing entity in the biotechnology sector, is captivating investor attention with its remarkable potential upside of 142.78%. This is driven by its strategic focus on..

Dynavax Technologies Corporation (DVAX) Investor Outlook: Exploring a 116% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a key player in the healthcare sector, is garnering attention from investors due to its promising growth prospects and a notable potential upside of 116.08%...

US Broker Ratings

US Broker Ratings

FTSE 100

Funds